Logo image of FTRE

FORTREA HOLDINGS INC (FTRE) Stock Fundamental Analysis

NASDAQ:FTRE - Nasdaq - US34965K1079 - Common Stock - Currency: USD

15.07  +0.16 (+1.07%)

After market: 15.5 +0.43 (+2.85%)

Fundamental Rating

2

Taking everything into account, FTRE scores 2 out of 10 in our fundamental rating. FTRE was compared to 57 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of FTRE have multiple concerns. FTRE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

FTRE had positive earnings in the past year.
In the past year FTRE had a positive cash flow from operations.
FTRE Yearly Net Income VS EBIT VS OCF VS FCFFTRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

With a Return On Assets value of -8.28%, FTRE perfoms like the industry average, outperforming 56.14% of the companies in the same industry.
FTRE's Return On Equity of -20.04% is in line compared to the rest of the industry. FTRE outperforms 52.63% of its industry peers.
Industry RankSector Rank
ROA -8.28%
ROE -20.04%
ROIC N/A
ROA(3y)2.22%
ROA(5y)N/A
ROE(3y)2.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FTRE Yearly ROA, ROE, ROICFTRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

In the last couple of years the Operating Margin of FTRE has declined.
FTRE's Gross Margin of 18.49% is on the low side compared to the rest of the industry. FTRE is outperformed by 80.70% of its industry peers.
In the last couple of years the Gross Margin of FTRE has declined.
The Profit Margin and Operating Margin are not available for FTRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.49%
OM growth 3Y-10.89%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5YN/A
FTRE Yearly Profit, Operating, Gross MarginsFTRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

FTRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
FTRE has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, FTRE has a worse debt to assets ratio.
FTRE Yearly Shares OutstandingFTRE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
FTRE Yearly Total Debt VS Total AssetsFTRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

FTRE has an Altman-Z score of 0.97. This is a bad value and indicates that FTRE is not financially healthy and even has some risk of bankruptcy.
FTRE has a Altman-Z score of 0.97. This is in the lower half of the industry: FTRE underperforms 63.16% of its industry peers.
The Debt to FCF ratio of FTRE is 5.11, which is a neutral value as it means it would take FTRE, 5.11 years of fcf income to pay off all of its debts.
FTRE has a Debt to FCF ratio of 5.11. This is in the better half of the industry: FTRE outperforms 68.42% of its industry peers.
FTRE has a Debt/Equity ratio of 0.74. This is a neutral value indicating FTRE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, FTRE is doing worse than 71.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 5.11
Altman-Z 0.97
ROIC/WACCN/A
WACC10.96%
FTRE Yearly LT Debt VS Equity VS FCFFTRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

FTRE has a Current Ratio of 1.18. This is a normal value and indicates that FTRE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.18, FTRE is doing worse than 84.21% of the companies in the same industry.
FTRE has a Quick Ratio of 1.18. This is a normal value and indicates that FTRE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.18, FTRE is doing worse than 73.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
FTRE Yearly Current Assets VS Current LiabilitesFTRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for FTRE have decreased strongly by -232.89% in the last year.
FTRE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -48.90%.
The Revenue has been growing slightly by 6.41% on average over the past years.
EPS 1Y (TTM)-232.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.17%
Revenue 1Y (TTM)-48.9%
Revenue growth 3Y6.41%
Revenue growth 5YN/A
Sales Q2Q%-13.07%

3.2 Future

The Earnings Per Share is expected to grow by 17.86% on average over the next years. This is quite good.
Based on estimates for the next years, FTRE will show a small growth in Revenue. The Revenue will grow by 1.53% on average per year.
EPS Next Y-60.59%
EPS Next 2Y-0.29%
EPS Next 3Y9.8%
EPS Next 5Y17.86%
Revenue Next Year-13.08%
Revenue Next 2Y-6.3%
Revenue Next 3Y-2.81%
Revenue Next 5Y1.53%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
FTRE Yearly Revenue VS EstimatesFTRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
FTRE Yearly EPS VS EstimatesFTRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 43.06, which means the current valuation is very expensive for FTRE.
FTRE's Price/Earnings ratio is a bit cheaper when compared to the industry. FTRE is cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of FTRE to the average of the S&P500 Index (28.20), we can say FTRE is valued expensively.
A Price/Forward Earnings ratio of 11.42 indicates a reasonable valuation of FTRE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FTRE indicates a rather cheap valuation: FTRE is cheaper than 98.25% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 94.48. FTRE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 43.06
Fwd PE 11.42
FTRE Price Earnings VS Forward Price EarningsFTRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

FTRE's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FTRE indicates a rather cheap valuation: FTRE is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.14
EV/EBITDA 760.2
FTRE Per share dataFTRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.29%
EPS Next 3Y9.8%

More info and screens

0

5. Dividend

5.1 Amount

FTRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORTREA HOLDINGS INC

NASDAQ:FTRE (2/10/2025, 3:42:10 PM)

After market: 15.5 +0.43 (+2.85%)

15.07

+0.16 (+1.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)03-03 2025-03-03/bmo
Inst Owners115.44%
Inst Owner Change-43.01%
Ins Owners0.28%
Ins Owner Change33.12%
Market Cap1.35B
Analysts52.5
Price Target22.13 (46.85%)
Short Float %6.62%
Short Ratio5.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-72.29%
Min EPS beat(2)-134.75%
Max EPS beat(2)-9.84%
EPS beat(4)0
Avg EPS beat(4)-193.86%
Min EPS beat(4)-608.63%
Max EPS beat(4)-9.84%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-5.76%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-5.93%
Min Revenue beat(4)-13.98%
Max Revenue beat(4)-1.96%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.24%
PT rev (3m)-2.69%
EPS NQ rev (1m)-2.12%
EPS NQ rev (3m)-13.6%
EPS NY rev (1m)-1.57%
EPS NY rev (3m)-4.45%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)-3.98%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 43.06
Fwd PE 11.42
P/S 0.49
P/FCF 6.14
P/OCF 5.24
P/B 0.89
P/tB N/A
EV/EBITDA 760.2
EPS(TTM)0.35
EY2.32%
EPS(NY)1.32
Fwd EY8.76%
FCF(TTM)2.45
FCFY16.27%
OCF(TTM)2.88
OCFY19.09%
SpS30.93
BVpS16.87
TBVpS-10.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.28%
ROE -20.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.49%
FCFM 7.93%
ROA(3y)2.22%
ROA(5y)N/A
ROE(3y)2.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-10.89%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5YN/A
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 5.11
Debt/EBITDA 362.74
Cap/Depr 42.33%
Cap/Sales 1.37%
Interest Coverage N/A
Cash Conversion 8325.81%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 0.97
F-Score3
WACC10.96%
ROIC/WACCN/A
Cap/Depr(3y)38.81%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-232.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.17%
EPS Next Y-60.59%
EPS Next 2Y-0.29%
EPS Next 3Y9.8%
EPS Next 5Y17.86%
Revenue 1Y (TTM)-48.9%
Revenue growth 3Y6.41%
Revenue growth 5YN/A
Sales Q2Q%-13.07%
Revenue Next Year-13.08%
Revenue Next 2Y-6.3%
Revenue Next 3Y-2.81%
Revenue Next 5Y1.53%
EBIT growth 1Y-123.7%
EBIT growth 3Y-5.17%
EBIT growth 5YN/A
EBIT Next Year21.43%
EBIT Next 3Y21.52%
EBIT Next 5Y16.54%
FCF growth 1Y283.99%
FCF growth 3Y-10.43%
FCF growth 5YN/A
OCF growth 1Y91.31%
OCF growth 3Y-5.9%
OCF growth 5YN/A